IBD – Buhlmann Diagnostics Corp

Tag: IBD

Clinical trial of the use of the smartphone-based health applications IBDsmart and IBDoc

IBDoc® Citation: ECCO 2019 Poster Walmsley et al. Poster: P630 A non-inferiority randomised clinical trial of the use of the smartphone-based health applications IBDsmart and IBDoc® in the care of inflammatory bowel disease patients. ECCO 2019: Inflammatory Bowel Diseases 14th Congress, March 6-9, 2019, Copenhagen/Denmark. Highlights from this Publication   “Use of IBDsmart and IBDoc® in
Continue Reading

Biomarkers as predictors of flares in inflammatory bowel disease

BÜHLMANN sCAL ELISA: Lavric M et al.: Biomarkers as Predictors of Flares in Inflammatory Bowel Disease. Poster presented at final MIAMI Meeting (Translating Science into targets); 2016: April 13-15, Muenster (Germany). View Poster BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

A Pilot Study Using Point of Care Testing for Infliximab and Faecal Calprotectin in IBD Patients

BÜHLMANN Quantum Blue® Infliximab Citation: Sophie Restellini, Talat Bessissow, Carolyne Lemieux, Che-Yung Chao, Gary Wild, Ernest Seidman, Alain Bitton, Peter L. Lakatos, Waqqas Afif.  P711 A pilot study using point of care testing for infliximab and faecal calprotectin in IBD patients with a secondary loss of response.  Journal of Crohn's and Colitis. 2018 Jan. DOI: 10.1093/ecco-jcc/jjx180.838. Highlight from this
Continue Reading